STOCK TITAN

Valion Bio, Inc. (VBIO) Total Assets by Year

VBIO

Valion Bio, Inc. closed fiscal year 2025 with $31.6M in total assets, $14.8M in total liabilities and $16.8M in shareholder equity. This represents an increase of 1026.0% from the prior fiscal year. The table below carries 5 fiscal years, from 2021 to 2025, and the quarters Valion Bio, Inc. has filed alongside them.

FY2025 annual
Total Assets $31.6M
Total Liabilities $14.8M
Total Equity $16.8M
YoY +1026.0%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

VBIO Balance Sheet by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-K
Total Assets$31.6M+1026.0%$2.8M-45.6%$5.2M-12.2%$5.9M-60.9%$15.0M
Total Liabilities$14.8M+5344.9%$272K-82.8%$1.6M-29.8%$2.2M+27.3%$1.8M
Total Equity$16.8M+562.6%$2.5M-29.2%$3.6M-1.4%$3.6M-72.6%$13.3M

VBIO Balance Sheet by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Total Assets$32.5M+620.3%$38.2M+911.8%$31.6M+1026.0%$6.2M+83.5%$4.5M-5.7%$3.8M+14.9%$2.8M-45.6%$3.4M-51.6%$4.8M+4.1%$3.3M-53.7%$5.2M-12.2%$7.0M-14.6%
Total Liabilities$28.2M+3338.1%$19.7M+2554.1%$14.8M+5344.9%$2.8M+402.7%$821K+38.9%$741K-34.6%$272K-82.8%$560K-54.9%$591K-58.8%$1.1M-40.2%$1.6M-29.8%$1.2M-49.0%
Total Equity$4.2M+15.2%$11.1M+264.4%$16.8M+562.6%$3.4M+20.5%$3.7M-12.0%$3.0M+41.0%$2.5M-29.2%$2.8M-50.8%$4.2M+32.6%$2.2M-58.6%$3.6M-1.4%$5.8M-0.1%

What total assets means

Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.

More Valion Bio, Inc. financials

Frequently Asked Questions

What was Valion Bio, Inc.'s total assets in fiscal year 2025?

Valion Bio, Inc. closed fiscal year 2025 with $31.6M in total assets, $14.8M in total liabilities and $16.8M in shareholder equity.

How fast is Valion Bio, Inc.'s total assets growing?

Valion Bio, Inc. (VBIO) total assets rose by 1026.0% year over year, from $2.8M to $31.6M in fiscal year 2025.

How has Valion Bio, Inc.'s total assets changed over the years?

Across the 5 fiscal years this page covers, Valion Bio, Inc. (VBIO) total assets went from $15.0M in fiscal year 2021 to $31.6M in fiscal year 2025.

Valion Bio, Inc. (VBIO) reported $32.5M in total assets in Q2 2026. This represents an increase of 620.3% from the same quarter a year earlier.

Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Valion Bio, Inc. (VBIO) reported on that line in every period on record.